An unusual cause of severe persistent neutropenia in a child with nephrotic syndrome

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Kshirsagar, Archana A ^a   Reid, Christopher J D ^a   Alamelu, Jayanthi ^a   Sinha, Manish D ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIHYPERTENSIVE AGENT; CD19 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; STEROID; TACROLIMUS; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ARTICLE; CASE REPORT; CHILD; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG FEVER; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ECHOGRAPHY; GENERALIZED EDEMA; HAIR; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTROPHY; HYPOALBUMINEMIA; KIDNEY BIOPSY; LOW DRUG DOSE; MALE; NEPHROTIC SYNDROME; NEUTROPENIA; NEUTROPHIL COUNT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; SIDE EFFECT; SINGLE DRUG DOSE; THROMBOCYTE COUNT; VOMITING; CHEMICALLY INDUCED;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CHILD, PRESCHOOL; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOLOGIC FACTORS; MALE; NEPHROTIC SYNDROME; NEUTROPENIA; RITUXIMAB;

EID: 84891671565     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-007958     Document Type: Article

References (12)

1. Haffner D, Fischer DC. Nephrotic syndrome and rituximab:facts and perspectives. Paediatr Nephrol 2009;24:1433-8.
2. Guigonis V, Dallocchio A, Baudouin V, et al. Rituximab treatment for severe steroidor cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 2008;23:1269-79.
3. Gulati A, Sinha A, Jordan SC, et al. Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 2010;5:2207-12.
4. Kamei K, Ito S, Nozu K, et al. Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol 2009;24:1321-8.
5. Kemper MJ, Gellermann J, Habbig S, et al. Long term follow-up after rituximab for steroid dependent idiopathic nephrotic syndrome. Nephrol Dial Transplant 2012;27:1910-15.
6. Sellier-Leclerc AL, Macher MA, Loirat C, et al. Rituximab efficiency in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 2010;25:1109-15.
7. Chaumais MC, Garnier A, Chalard F, et al. Fatal pulmonary fibrosis after rituximab administration. Pediatr Nephrol 2009;24:1753-5.
8. Bitzan M, Anselmo M, Carpineta L. Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature. Pediatr Pulmonol 2009;44:922-34.
9. Dunleavy K, Tay K, Wilson WH. Rituximab-associated neutropenia. Semin Hematol 2010;47:180-6.
10. Voog E, Morschhauser F, Solal-Celigny P. Neutropenia in patients treated with rituximab. N Engl J Med 2003;348:2691-4.
11. Besada E, Koldingsnes w, Nossent J. Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a case review analysis from a single center. QJM 2012;105:545-50.
12. Larrar S, Guitton C, Willems M, et al. Severe hematological side-effects following rituximab therapy in children. Haematologica 2006;91:ECR36.